Levetiracetam Combix (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates the release of neurotransmitters. By influencing this pathway, the drug stabilises neuronal firing and diminishes the hyper‑excitability that leads to seizure activity, providing an anticonvulsant effect.

The specific dose of Levetiracetam Combix is determined by the prescribing clinician based on the patient’s age, weight, renal function and seizure type. Healthcare professionals tailor the regimen to achieve optimal seizure control while minimising side effects.

Safety data for levetiracetam in pregnancy and lactation are limited. The medication should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Consultation with a healthcare provider is essential before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancing agents such as valproate. It is generally well tolerated, has fewer drug‑enzyme interactions, and can be used as monotherapy or adjunctive therapy in many seizure types.

Levetiracetam Combix should be stored at room temperature, below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Levetiracetam Combix is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with water and not crushed or chewed unless specifically advised by a healthcare professional.

Serious risks include severe allergic reactions such as anaphylaxis, skin conditions like Stevens‑Johnson syndrome, and psychiatric effects including suicidal thoughts or severe mood changes. Patients should seek immediate medical attention if they notice any of these symptoms.

Levetiracetam Combix is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for patients with severe renal impairment who may require dose adjustment, and it should be avoided in those where the risk outweighs potential benefit.